The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …

Earlier variants of SARS-CoV-2 have been associated with hypercoagulability and an
extensive formation of fibrin amyloid microclots, which are considered to contribute to the …

Background Thrombo-inflammation is an important checkpoint that orchestrates infarct
development in ischemic stroke. However, the underlying mechanism remains largely …

An important component of severe COVID-19 disease is virus-induced endothelilitis. This
leads to disruption of normal endothelial function, initiating a state of failing normal clotting …

With the arrival of the Covid-19 pandemic, anti-viral agents have regained center stage in
the arena of medicine. Out of the various drug targets involved in managing RNA-viral …

Platelet adhesion and activation are essential initial processes of arterial and microvascular
hemostasis, where high hydrodynamic forces from the bloodflow impede coagulation. The …

Coronavirus disease COVID-19, which is caused by severe acute respiratory syndrome
coronavirus SARS-CoV-2, has become a worldwide pandemic in recent years. In addition to …

The prevailing hypotheses for the persistent symptoms of Long COVID have been narrowed
down to immune dysregulation and autoantibodies, widespread organ damage, viral …

The coronavirus SARS-CoV2 disease (COVID-19) is connected with significant morbidity
and mortality (3.4%), disorders in hemostasis, including coagulopathy, activation of platelets …

Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein
thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in …